Nourish Raises $100M Series C for AI-Powered Metabolic Health

Nourish, a dietitian-led metabolic health clinic, has raised $100 million in Series C funding, bringing its total to $215 million. The new funding will be used to expand its clinical network, develop AI tools, improve its care model, and work more closely with health plans and employers. Evidence from studies suggests that Nourish's telehealth approach may help with lifestyle outcomes, such as diet and physical activity, but results for some health markers are mixed. The company appears to be well positioned for growth, but it is not yet clear if it will be acquired or go public.

Nourish, a leading dietitian-led metabolic health clinic, has raised substantial Series C funding to advance its AI-powered telehealth platform. This latest investment brings the company's total funding to a significant amount, highlighting investor confidence in scaling solutions for chronic metabolic conditions.

What is Nourish and why did it just raise substantial funding?

Nourish is a U.S.-based telehealth clinic using registered dietitians and AI to manage metabolic conditions. The company raised substantial Series C funding to scale its clinical network, develop its technology, and expand partnerships with health plans to address chronic diseases like diabetes and obesity.

As the largest dietitian-led metabolic health clinic in the United States, Nourish pairs licensed registered dietitians with an AI-native telehealth platform to help patients manage and reverse chronic conditions like type 2 diabetes, obesity, and hypertension. The company announced the closing of the Series C round in May 2026 (source).

How will the new capital be used?

According to CEO Aidan Dewar, the fresh capital will be allocated to four strategic priorities:

Expand the Clinical Network: Recruit additional registered dietitians and physicians to meet growing patient demand.
Accelerate AI Development: Deploy new AI agents to personalize nutrition plans for patients and automate routine tasks for providers.
Scale the Care Model: Grow the company's metabolic clinic model nationwide through strategic partnerships with health plans, employers, and health systems.
Deepen Payer Integrations: Secure more value-based contracts that link reimbursement to measurable health outcomes, such as improvements in HbA1c, weight loss, and blood pressure.

Who invested, and what does that signal?

The Series C round was led by Menlo Ventures, with participation from existing backers including Thrive Capital and Index Ventures. The syndicate also featured J.P. Morgan Growth Equity Partners, Maverick Ventures, Y Combinator, BoxGroup, Atomico, Daybreak, and Operator Partners.

This blend of Silicon Valley venture capital and East-coast growth equity firms signals broad market confidence in Nourish's potential to operate at a health-system scale, moving beyond a niche point solution.

Does dietitian-led telehealth actually improve metabolic outcomes?

Recent peer-reviewed studies indicate that while dietitian-led telehealth models show strong results for lifestyle changes, the impact on key cardiometabolic markers is more varied.

Weight & Lipids: A meta-analysis of telenutrition programs found moderate, consistent improvements in weight, waist circumference, and triglycerides (reference).
HbA1c: Telemedicine interventions generally reduced HbA1c versus usual care by roughly 0.38% to 0.59% in recent studies.
Blood Pressure: Studies have found that remote lifestyle coaching led by dietitians can improve various cardiovascular markers, though results vary across different blood pressure measurements and study designs.

How big is the market for AI-driven metabolic care right now?

Nourish's funding success occurs amid a period of intense capital concentration in the digital health sector, particularly for companies targeting obesity and diabetes.

U.S. digital health startups raised substantial funding in 2025, according to industry reports (Rock Health).
AI-enabled companies were a major focus, capturing a significant portion of those funds and commanding premium valuations according to industry reports (Rock Health).
Large funding rounds accounted for a substantial portion of all digital health investment dollars in 2025 according to industry analysts (Galen Growth).

With investors heavily backing obesity and GLP-1-adjacent startups, Nourish's model, which combines dietitian expertise with AI support, is positioned at the center of a major investment trend in metabolic care.